Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Starbucks
SBUX
$122B
| $125M | 0.06% |
2,300,372
+1,414,970
| +160% | +$79.1M |
|
277
CALL
Skyworks Solutions
SWKS
$10.1B
| $124M | 0.06% |
1,633,000
+512,700
| +46% | +$35.7M |
|
278
Biogen
BIIB
$32B
| $124M | 0.06% |
396,042
-47,534
| -11% | -$14.1M |
|
279
PUT
State Street SPDR S&P Retail ETF
XRT
$491M
| $124M | 0.06% |
2,843,200
+1,701,300
| +149% | +$75.3M |
|
280
CALL
UnitedHealth
UNH
$350B
| $123M | 0.06% |
878,600
+146,300
| +20% | +$20.5M |
|
281
CALL
American Express
AXP
$227B
| $123M | 0.06% |
1,919,700
-374,400
| -16% | -$24.1M |
|
282
CALL
VanEck Junior Gold Miners ETF
GDXJ
$9.76B
| $123M | 0.06% |
2,772,100
+261,600
| +10% | +$12.4M |
|
283
PUT
ConocoPhillips
COP
$162B
| $123M | 0.06% |
2,821,600
+100
| +0% | +$4.16K |
|
|
AGN
284
DELISTED
Allergan plc
AGN
| $121M | 0.06% |
526,898
-162,585
| -24% | -$39.7M |
|
285
PUT
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.31B
| $121M | 0.06% |
3,022,200
+281,800
| +10% | +$10.6M |
|
286
CALL
Crown Castle
CCI
$32.1B
| $120M | 0.06% |
1,277,800
+18,100
| +1% | +$1.74M |
|
287
CALL
eBay
EBAY
$46.3B
| $120M | 0.06% |
3,650,500
+196,200
| +6% | +$5.92M |
|
288
CALL
Delta Air Lines
DAL
$54.2B
| $120M | 0.06% |
3,050,100
-816,100
| -21% | -$30.9M |
|
289
Blackstone
BX
$108B
| $119M | 0.06% |
4,677,957
+586,488
| +14% | +$15.5M |
|
|
X
290
CALL
DELISTED
US Steel
X
| $119M | 0.06% |
6,293,400
+2,973,700
| +90% | +$61.4M |
|
|
291
PUT
VanEck Junior Gold Miners ETF
GDXJ
$9.76B
| $118M | 0.06% |
2,663,500
+1,900,300
| +249% | +$90M |
|
292
CALL
DuPont de Nemours
DD
$18.7B
| $118M | 0.06% |
897,407
-133,351
| -13% | -$17.8M |
|
293
CALL
3M
MMM
$92.3B
| $117M | 0.06% |
796,058
-108,118
| -12% | -$16.1M |
|
294
PUT
Ulta Beauty
ULTA
$22.4B
| $115M | 0.06% |
483,600
+183,400
| +61% | +$46.3M |
|
295
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
| $113M | 0.05% |
1,944,100
+497,700
| +34% | +$28.9M |
|
296
CALL
NXP Semiconductors
NXPI
$56.9B
| $113M | 0.05% |
1,109,700
+397,600
| +56% | +$33.7M |
|
297
PUT
Visa
V
$693B
| $113M | 0.05% |
1,366,300
-479,900
| -26% | -$38.4M |
|
298
CALL
Yum! Brands
YUM
$41.8B
| $113M | 0.05% |
1,727,622
-153,149
| -8% | -$9.77M |
|
|
WBA
299
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $112M | 0.05% |
1,385,300
-826,700
| -37% | -$67.4M |
|
300
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$45.4B
| $112M | 0.05% |
1,546,700
+429,300
| +38% | +$31.6M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.